Abstract
The use of clinical biomarkers, such as high-sensitivity C-reactive protein (hs-CRP), provides a more agile, less expensive and shorter clinical outcome. Currently, hs-CRP is widely used in routine laboratory tests as a nonspecific inflammatory marker, but it can be particularly useful in specific clinical conditions, such as guiding antibiotic therapy in neonatal sepsis and in the clinic…